Crossmark

Development and validation of Empagliflozin and Linagliptin simultaneous estimation in rat plasma using freezing lipid precipitation and SCX-SPE assisted HPLC–MS/MS method and its application in pharmacokinetic studies

Crossref DOI link: https://doi.org/10.1007/s44211-023-00444-z

Published Online: 2023-11-03

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thallapalli, Anil Kumar Goud

Manda, Ram Mohan https://orcid.org/0000-0003-4540-8280
License Information

Text and Data Mining valid from 2023-11-03

Version of Record valid from 2023-11-03
More Information

Article History

Received: 2 April 2023

Accepted: 27 September 2023

First Online: 3 November 2023

Declarations

:

: The authors have declared no conflicts of interest. None of the authors have any competing financial interests or personal relationships that might have appeared to influence their work.

: This article contains no studies with human participants or animals performed by authors.

Document is current

Any future updates will be listed below